Intrinsiqq
Adma Biologics Inc. logo

Adma Biologics Inc. Dividend Analysis

ADMA

⊜ Compare
Dividend0
No active dividend

This company has no dividend history.

Based on TTM and annual data · Not a buy/sell signal

This company does not pay dividends

No dividend history found in SEC filings.

Does Adma Biologics (ADMA) pay a dividend?

Adma Biologics (ADMA) has never paid a dividend. It returns cash through buybacks instead, at roughly a 8.0% buyback yield over the last twelve months. The business does generate free cash flow of $116 million, so the absence of a dividend is a capital-allocation choice rather than an inability to pay. All figures are computed from company filings; this is analysis, not investment advice.

Frequently asked

Does Adma Biologics (ADMA) pay a dividend?+

No. Adma Biologics (ADMA) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold.

How does Adma Biologics return cash to shareholders?+

Through share buybacks rather than dividends. Over the last twelve months Adma Biologics reduced its share count at a rate equivalent to a 8.0% buyback yield. A buyback returns value by shrinking the share count, so each remaining share owns more of the business, but unlike a dividend it pays you nothing in cash and can be stopped at any time without an announcement.

Could Adma Biologics afford to pay a dividend?+

On the numbers, yes. Adma Biologics generated $116 million of free cash flow, which is about $0.51 per share. If it paid out half of that, the dividend would be roughly $0.25 per share, a yield of about 2.4% at the current price. That is an illustration of capacity, not a prediction: the company has given no indication it intends to pay one.

Which healthcare companies do pay dividends?+

Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with Adma Biologics.

SourceDividend analysis computed from the 10-Q filed 31 Jul 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 19 Sept 2026. How this is calculated.

Fiscal year ends Dec. Earnings payout = dividends / net income. FCF payout = dividends / FCF. Yield = TTM DPS / price.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with ADMA

CompareIntrinsic value
KRYSKrystal Biotech Inc.
$310.84+1.90%44
TWSTTwist Bioscience Corporation
$142.58+1.63%40
IMCRImmunocore Holdings plc
$29.23-2.66%40
TARSTarsus Pharmaceuticals Inc.
$69.07-4.91%55
NVAXNovavax Inc.
$10.65+10.02%10
MGTXMeiraGTx Holdings plc
$9.42-1.05%74
DNLIDenali Therapeutics Inc.
$20.81+6.97%10
ADPTAdaptive Biotechnologies Corporation
$26.71+3.53%40

Held by ETFs

ADMA is in 76 US ETFs. The largest of them, with ADMA's weight in each:

Spot a number that looks wrong? Check it in ADMA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ADMA

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.